According to Astec Lifesciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.76851. At the end of 2023 the company had a P/S ratio of 4.94.
Year | P/S ratio | Change |
---|---|---|
2023 | 4.94 | 16.47% |
2022 | 4.24 | -12.52% |
2021 | 4.84 | 5.99% |
2020 | 4.57 | 148.16% |
2019 | 1.84 | -23.01% |
2018 | 2.39 | -28.37% |
2017 | 3.34 | -15.78% |
2016 | 3.97 | 113.92% |
2015 | 1.85 | 125.96% |
2014 | 0.8204 | 214.46% |
2013 | 0.2609 | -23.57% |
2012 | 0.3413 |